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Purpose/Objective: To implement a time effective solution 
to enable radiotherapy centres across the UK to remotely 
access and register a database of CT/CBCT images. The 
purpose was to facilitate the IGRT training and assessment of 
RTTs throughout the UK in order to provide QA for those 
clinical trials requiring IGRT. 
Materials and Methods: The process was initially 
implemented for the HYpofractionated Bladder Radiotherapy 
with or without Image guided aDaptive planning (HYBRID) 
Trial (CRUK/12/055), requiring CBCT analysis for plan of the 
day selection. The anonymised treatment datasets from 5 
patients, each containing 6 CT/CBCT images registered to the 
acquisition position, were imported into two vendor systems. 
Three patient cases (18 CBCT images) and the consensus plan 
of the day selection, consistent with the HYBRID Trial RT 
guidelines, were provided for training. 2 patient cases (12 
CBCT images) were provided for assessment. Detailed 
instructions and support were provided for participating 
centres in remotely accessing their vendor appropriate 
database.  
Individual centres were asked to complete an internet survey 
to obtain feedback on the process regarding image quality, 
usability, and general experience. 
Results: Remote training has been accessed by 10 
Radiotherapy centres across the UK recruiting patients into 
the HYBRID Trial. One centre completed the training as a 
group, while others accessed individually. The assessment 
required individuals to perform a bladder registration of CT 
and CBCT, and select the correct treatment plan from a 
library of 3 plans. This has been completed by 67 Individuals. 
54 individuals successfully completed the assessment cases 
with a pass mark of 83% (10/12 cases) or above on a first 
attempt; the remaining 13 achieved the pass mark on a 
second attempt following verbal feedback on the QA process. 
A pre-requisite of the adaptive trial was that centres had 
previous experience in CBCT soft tissue analysis for bladder 
cancer. The majority of centres (70%) reported individuals 
taking less than 1 hour to complete the training cases and 
86% of the respondents reported that the image quality 
across the systems was sufficient for them to effectively 
carry out the assessment. 
All centres responded that the training and assessment cases 
provided were sufficient to familiarise them with the trial 
protocol, and that the training and assessment had prepared 
them for plan selection within the trial. 
Conclusions: It is feasible and practical to use remote 
systems to train and assess IGRT competency for multi-centre 
clinical trials. This solution will be extended to UK clinical 
trials involving IGRT for other anatomical sites.  
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Purpose/Objective: In case of prostatic irradiation, dose 
constraints are designed for the whole rectum. A rectal sub-
region (RSR) may be especially involved in the risk of toxicity 
and may be highly predictive of toxicity. The goal of this 
work was to characterize this RSR. 
Materials and Methods: A total of 118 patients (pts) having 
received a total dose of 80Gy in prostate by IMRT with IGRT 
were included in this study. Rectal bleeding (RB) at three 
years was analyzed (≥ grade 1). A total of 31pts suffered from 
RB. Following a leave-one-out cross validation scheme, each 
patient was chosen as anatomical template of reference 
(ATR) towards which the anatomies of the 117 remaining 
patients were non-rigidly registered. The planned dose 
distributions of each patient were then propagated into the 
space of the ATR. A voxel-wise comparison (Mann-Whitney) 
was performed between the registered dose distributions of 
the two groups of pts (i.e. pts with or without RB). This 
enabled the segmentation of a RSR where the difference of 
dose between the two groups was significant (p<0.05). This 
RSR was then spatially characterized and its predictive 
performances were quantified by the area under the curve 
(AUC) resulting from logistic regression at each bin of its 
DVH.  
Results: The average volume of the identified RSRs was 
2.8cm3 (3.4% of the absolute rectal volume). The RSRs were 
mostly located in the anterior rectal wall (90% of the volume 
located at less than 16mm from the prostate) and in the 
inferior part of the rectum. In these RSRs, pts with RB 
received in average 3.8Gy more than the pts without RB. The 
AUC in the RSR was 71% whereas the AUC was 63% at the 
maximum in the other evaluated full rectum or rectal sub-
regions (anterior rectal wall only…).  
 
Conclusions: The identified RSR, likely involved in the risk of 
toxicity, is located in the anterior rectal wall, in the inferior 
part of the rectum. The RSR could be subject to specific dose 
constraints at the inverse planning step of IMRT to reduce the 
risk of toxicity, and be used to predict the risk of rectal 
bleeding. 
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Purpose/Objective: A general principle in patient radiation 
protection is to give the smallest effective dose in diagnostic 
or in therapy procedures. Patients benefiting from Breast 
Conservative Treatment (BCT) will all require adjuvant 
radiotherapy. This radiotherapy is usually performed with 
external beam radiation but can be, in selected cases, also 
delivered intra-operatively in a single session. The purpose of 
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this study is to report the measured body exposures treated 
with single dose intra-operative electron radiation therapy 
(IOERT) in a large cohort of patients and to analyze which 
beam parameters impact the body exposure. 
Materials and Methods: During an almost 5-year period, 
more than 500 Partial Breast Irradiation (PBI) procedures 
have been performed with IOERT in our institution for pT1N0 
unicentric ductal breast carcinoma. A dose of 21 Gy was 
prescribed at the 90% isodose depth. Beam delivery was 
achieved with a Mobetron 1000 (Intraop, Sunnyvale, Ca). This 
mobile accelerator produces 4, 6, 9 and 12 MeV electron 
Beams with a 10Gy/min dose rate. Although the Mobetron is 
self-shielded device, a small component of straight X-rays 
radiation is always present during treatment delivery. In 
order to measure their body exposure coming from this 
straight radiation, three LiF Thermo-Luminescent Dosimeters 
(TLD) were positioned on each patient, respectively on the 
thyroid, on the contralateral breast and at the gonads level. 
The TLD were placed in an Aluminum container thick enough 
to provide electronic equilibrium and to stop any scattered 
electrons. TLDs were directly read just after PBI in a manual 
Harshaw reader under Nitrogen flow. 
As a comparison, the body exposure in a series of 30 BCT 
patients treated with 6 MV external beams was measured in 
the same way.  
Results: Mean doses for PBI treatments on the thyroid, 
contralateral breast and gonads were 0.82, 0.41 and 0.14 cGy 
respectively. Higher energy beam gives significant higher 
body exposure. The field size, ranging from 35 mm to 65 mm 
does not influence the body exposure. On the other hand, the 
treated quadrant has an impact on measured doses. Patients 
treated with external radiation received much higher body 
doses, from 25 times to more than 100 times higher for the 
contralateral breast. 
Conclusions: As radiation protection is concerned, IOERT is a 
safe procedure and gives very small body doses, unlikely to 
increase the carcinogenetic risk significantly, especially in 
the contralateral breast. Pregnant women might, in certain 
circumstances and with additional safety measures, be 
treated with the IOERT approach with an acceptable fetal 
dose.  
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Purpose/Objective: To evaluate the necessity of using an 
image modality in order to improve and adapt the IORT 
dosimetry based on Monte Carlo simulations. 
Materials and Methods: A model of the Intrabeam™ system 
has been previously developed with the GATE platform taking 
into account the different parts of the device. This study was 
performed on 25 patients. A preoperative CT acquisition of 
the patient breast was performed and included in the 
simulation allowing accurate dose calculation (Figure 1).  
 
During IORT, in vivo dosimetry was performed on 15 patients 
using thermoluminescent dosimeters (TLD) placed on the skin 
at 1 and 3 cm around the spherical applicator. First, 
comparison between simulation results on GATE and TLD 
measurements have been performed to confirm the dose 
prediction at the TLD locations. The dose simulated was 
recorded at the same initial position of the TLD. The depth 
dose curves between MC simulations and software computed 
doses have been compared. Then, the dosimetric influence of 
the applicator’s position was simulated: the applicator has 
been moved from 5 mm to 10 mm around its initial position. 
Finally, in addition to pre-operative CT acquisition, an 
intraoperative CT has been acquired on three patients in 
order to validate the overall dosimetric evaluation protocol.  
Results: Patient results showed a good agreement between 
clinical experiments and simulations. Indeed the relative 
mean deviation between TLD and GATE dose measurements 
was 0.1% ± 0.11% with a maximum of 0.33%. The simulation 
uncertainty was less than 1% (from 0.41% to 0.95%). Breast 
densities significantly changed the depth dose curves 
compared to the one given by the Intrabeam software which 
consider the breast as homogeneous. Considering the 
applicator displacement, the mean percentage deviation of 
the dose was 6.3% ±44.9%, 8.8% ±89% at 5 mm and 10 mm 
respectively. These results indicated that the dosimetry was 
greatly influenced when moving the applicator position due 
to the high dose fall-off of the low energy x-ray source.  
Conclusions: We proposed the use of an accurate model of 
the Intrabeam system on the GATE platform accounting for 
the tissues heterogeneities. Using a pre-surgery image 
modality could greatly optimize the dosimetry by 
determining a better applicator position. The dosimetric 
evaluation of the proposed platform with patient datasets 
supports its use for patient specific dosimetry planning. By 
this way we should be able to adapt a personalized dosimetry 
and not also prescribe the same dose to all the patients.  
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